This might include: Slowly stopping the drug Eating well Staying active Getting support Summary Table For Side Effects Maximising Results with GLP-1s for Craving and Weight Control Healthy eating, physical activity, and behavioural support can improve overall treatment outcomes
Primary indication is diabetes management based on blood glucose criteria, not BMI
Whether its the inability to participate in physical activities, travel, or maintain social relationships, this damage reflects a significant change in lifestyle
Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study
Do not independently use a dose change as a nausea-management strategy
Overall, long-acting GLP-1 receptor agonists were more effective in reducing weight than short-acting formulations